RxDoctor Payments Data

Michael Pendola, MD

Colon & Rectal Surgery · Dallas, TXNPI 1932279577

Payments from drug & device makers

What this record shows

This record is dominated by education: $15,013 of the $20,969 with a category attached, or 71.6%. Intuitive Surgical accounts for 72.2% of it on its own, with 32 other manufacturers making up the rest. Reporting peaked in 2022 at $10,129 and has fallen 95.3% since, to $473 in 2025.

$20,969in general payments, 2019–2025

Across 307 payments — averaging $68.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$15K
  • AbbVie$2K
  • Takeda Pharmaceuticals U.S.A., Inc.$955
  • THD America, Inc.$444
  • Merck$390
  • Stryker$214
  • plus $2K from 27 others

What the payments were for

  • Food & beverage$5,93628%
  • Education$15,01372%
  • Gifts$210%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$20,969 in reported general payments places this provider in the 80th percentile of 200 colon & rectal surgery providers in Texas.

See all colon & rectal surgery providers in Texas

Medicare billing

Part B allowed, 2024
$130,746
Medicare patients
287
Services billed
638

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mesalamine12$13,531
Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine25$1,042
Azathioprine13$413
Sulfasalazine11$399
Hydrocortisone13$238
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen19$201
Procto-Med HcHydrocortisone11$175
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav17$153
Tramadol Hcl12$34

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →